Akari Therapeutics Stock Forecast

Sell candidate since Jul 17, 2026 Loss -15.58%

The Akari Therapeutics Plc stock price fell by -12.80% on the last day (Tuesday, 21st Jul 2026) from $10.66 to $9.30. It has now fallen 5 days in a row. During the last trading day the stock fluctuated 35.99% from a day low at $9.05 to a day high of $12.30. The price has fallen in 8 of the last 10 days and is down by -39.95% for this period. Volume has increased on the last day by 16 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 70 thousand shares were bought and sold for approximately $649.88 thousand.

The stock lies in the lower part of a very wide and strong rising trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $8.98 is broken, it will firstly indicate a slower rate of rising, but may also be an early warning for a trend shift. Given the current short-term trend, the stock is expected to rise 44.22% during the next 3 months and, with a 90% probability hold a price between $12.95 and $38.83 at the end of this 3-month period.

AKTX Signals & Forecast

Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The Akari Therapeutics Plc stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $11.62 and $12.57. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Thursday, May 28, 2026, and so far it has fallen -57.85%. Further fall is indicated until a new bottom pivot has been found. Akari Therapeutics Plc gained volume on the last day, but on falling prices. In technical terms, this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-offs".

Support, Risk & Stop-loss for Akari Therapeutics Plc stock

There is no support from accumulated volume below today's level and given the right condition the stock may perform very badly in the next couple of days.

This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved $3.26 between high and low, or 35.99%. For the last week, the stock has had daily average volatility of 16.32%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (AKTX) For The Upcoming Trading Day Of Wednesday 22nd

For the upcoming trading day on Wednesday, 22nd we expect Akari Therapeutics Plc to open at $10.21, and during the day (based on 14 day Average True Range), to move between $8.38 and $10.21, which gives a possible trading interval of +/-$1.83 (+/-21.90%) up or down from last closing price. If Akari Therapeutics Plc takes out the full calculated possible swing range there will be an estimated 21.90% move between the lowest and the highest trading price during the day.

With no support below and resistance from accumulated volume @ $9.69, some $0.395 (4.25%) from the current price of $9.30, our system finds the risk reward not very attractive.

Is Akari Therapeutics Plc stock A Buy?

The Akari Therapeutics Plc stock holds several negative signals and despite the positive trend, we believe Akari Therapeutics Plc will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

Current score: -3.009 Sell Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on July 22, 2026 - $10.21 ( 9.88%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk